Login / Signup

Calcium channel blocker in patients with chronic kidney disease.

Shoko OhnoAkira IshiiMotoko YanagitaHideki Yokoi
Published in: Clinical and experimental nephrology (2021)
We should use different types of CCBs properly depending on their pharmacological effects, such as the strength of antihypertensive effects and the organ protection effects, taking into account the pathophysiology of the patients. In this article, the role and the use of CCBs in CKD patients are reviewed.
Keyphrases